WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008092257) USE OF CATECHOLAMINES AND RELATED COMPOUNDS AS ANTI-ANGIOGENIC AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/092257    International Application No.:    PCT/CA2008/000191
Publication Date: 07.08.2008 International Filing Date: 29.01.2008
IPC:
A61K 31/137 (2006.01), A61K 31/216 (2006.01), A61K 31/222 (2006.01), A61K 31/36 (2006.01), A61K 31/445 (2006.01), A61K 31/495 (2006.01), A61K 31/522 (2006.01), A61P 9/00 (2006.01)
Applicants: NATIONAL RESEARCH COUNCIL OF CANADA [CA/CA]; 1200 Montreal Road, Ottawa, Ontario K1A 0R6 (CA) (For All Designated States Except US).
KONISHI, Yasuo [CA/CA]; (CA) (For US Only).
MAGOON, Joanne [CA/CA]; (CA) (For US Only).
JARUSSOPHON, Suwatchai [TH/CA]; (CA) (For US Only)
Inventors: KONISHI, Yasuo; (CA).
MAGOON, Joanne; (CA).
JARUSSOPHON, Suwatchai; (CA)
Agent: KOENIG, Hans; National Research Council of Canada, Intellectual Property Services Office, EG-12, Bldg. M-58, 1200 Montreal Road, Ottawa, Ontario K1A 0R6 (CA)
Priority Data:
60/897,814 29.01.2007 US
60/924,574 25.05.2007 US
Title (EN) USE OF CATECHOLAMINES AND RELATED COMPOUNDS AS ANTI-ANGIOGENIC AGENTS
(FR) UTILISATION DE CATECHOLAMINES ET DE COMPOSES ASSOCIES COMME AGENTS ANTI-ANGIOGENIQUES
Abstract: front page image
(EN)A catecholamine or related compound of formula (I) having (S)-configuration at β-carbon and having a lipophilicity greater than (S)- noradrenalme, a physiologically tolerated salt thereof, a prodrug thereof, a physiologically functional derivative thereof or any mixture thereof is useful as an anti-angiogemc agent A catecholamine or related compound of formula (II) in which a β-hydroxy group has been modified is also anti-angiogemc
(FR)L'invention concerne une catécholamine ou un composé associé de formule (I) dont le carbone ß a la configuration (S) et dont la lipophilicité est supérieure à celle de la (S)-noradrénaline, l'un de ses sels physiologiquement toléré, l'un de ses promédicaments, l'un de ses dérivés physiologiquement fonctionnel ou un mélange quelconque des composés précédents qui est utile en tant que catécholamine agent anti-angiogénique A ou un composé associé de formule (II) dont un groupe β-hydroxy a été modifié, qui est également anti-angiogénique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)